Cipla to distribute Lilly’s diabetes drugs Humalog and Trulicity in India
Cipla will expand access to Lilly’s diabetes drugs by leveraging its distribution capabilities and engaging its professionals
Merck, GSK terminate $4.5bn deal on cancer drug development
01 Oct 21The decision was based on discouraging clinical trial data to date, including results from the recent INTR@PID study…
Regeneron to supply additional doses of REGEN-COV to US government
15 Sep 21The biotechnology company will supply additional 1.4 million 1,200mg doses of REGEN-COV to the US government, at a…
AstraZeneca reaches settlement with EC over Vaxzevria delivery
06 Sep 21AstraZeneca will deliver 60 million doses by the end of Q3 2021, 75 million doses by the end…
Roche, Shape collaborate on AAV-based gene therapies for neurological diseases
25 Aug 21Shape Therapeutics will use its RNA editing platform RNAfix and AAVid platform for the development of gene therapies…
Autolus, Moderna sign licencing agreement for mRNA therapeutics
03 Aug 21Moderna will make an upfront payment for each target it licensed from Autolus, in addition to milestone payments…
Biovac teams up with Pfizer and BioNTech to produce Covid-19 vaccine in Africa
22 Jul 21Pfizer and BioNTech will immediately start technical transfer, on-site development and equipment installation activities
Merck, Universal partner to produce paediatric treatment for schistosomiasis
16 Jul 21The new drug is currently being tested in a Phase 3 clinical trial in Kenya and Côte d’Ivoire
Kintor, Fosun partner to commercialise proxalutamide in India and Africa
15 Jul 21The collaboration will focus on the emergency use authorisation, promotion, and sale of proxalutamide for the treatment of…
BMS partners with Eisai to co-develop cancer drug candidate
18 Jun 21Under the deal, BMS will develop and commercialise the drug in regions outside of the collaboration territories, while…